Comparative Pharmacology
Head-to-head clinical analysis: FML S versus OCUMYCIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FML S versus OCUMYCIN.
FML-S vs OCUMYCIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluorometholone is a synthetic corticosteroid that binds to the glucocorticoid receptor, modulating gene expression to inhibit phospholipase A2 activity, reduce prostaglandin and leukotriene synthesis, and suppress cytokine production. This results in decreased inflammation, edema, and immune cell infiltration. Sulfacetamide is a sulfonamide antibiotic that competitively inhibits dihydropteroate synthase, blocking folate synthesis and bacterial growth.
Ocimycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking peptide bond formation.
1-2 drops of 0.1% ophthalmic suspension into the conjunctival sac every 4 hours; may increase to every 2 hours in severe inflammation.
1-2 drops in affected eye(s) every 4 hours while awake, increasing to every 2 hours for severe infection. Ophthalmic ointment: 0.5-inch ribbon into conjunctival sac 2-4 times daily.
None Documented
None Documented
2.8-3.5 hours; prolonged to 8-12 hours in renal impairment or in neonates
Terminal elimination half-life is 12-18 hours in adults with normal renal function; prolonged to 24-36 hours in moderate renal impairment (CrCl 30-50 mL/min).
Renal (65-75% as unchanged drug and metabolites), biliary/fecal (15-25%)
Renal excretion accounts for 60-70% of elimination as unchanged drug, with 10-15% as inactive metabolites; biliary/fecal excretion contributes 20-30%, with enterohepatic recirculation noted.
Category C
Category C
Ophthalmic Antibiotic/Corticosteroid Combination
Ophthalmic Antibiotic